Coinbase founder's health company NewLimit raises $130 million in Series B funding

Foresight News reported that NewLimit, an anti-aging startup founded by Coinbase founder Brian Armstrong, has raised $130 million in Series B funding, led by Kleiner Perkins, with participation from Khoslav Ventures and Founders Fund. Brian Armstrong stated that NewLimit's research is based on a relatively new scientific field - epigenetic reprogramming, which can manipulate cells to restore them to a younger or healthier state.